Type 2 Diabetes Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
This trial has several groups (cohorts), each with different criteria:
Cohort 1 (General group):
- People under 18 years old who are able to give consent (or whose parent/guardian can consent on their behalf)
- People who are able to drink a glucose (sugar) drink within 10 minutes
- People who are already scheduled for a specific blood sugar test called an OGTT, or who agree to have one done
Cohort 2 (Autoantibody group):
- People under 18 years old who are able to give consent (or whose parent/guardian can consent on their behalf)
- People who have tested positive for two or more islet autoantibodies (specific proteins the immune system produces that can be linked to type 1 diabetes) at any point in the past
- People who are able to drink a glucose drink within 10 minutes
CGM Sub-study (Continuous Glucose Monitor group):
- People under 18 years old who are able to give consent (or whose parent/guardian can consent on their behalf)
- People who have a confirmed diagnosis of Stage 1, 2, or 3 type 1 diabetes
- People who are already participating in Cohort 1
- People who are able to drink a glucose drink within 10 minutes
Qualitative Sub-study (Interview/experience group):
- People who are able to give consent (or whose parent/guardian can consent on their behalf), AND either:
- A young person aged 15 or older who has tested positive for two or more islet autoantibodies, or a parent of a young person who has had a metabolic test such as an OGTT (a blood sugar test), OR
- A healthcare professional involved in delivering these types of metabolic tests
Cohort 3 (Prediabetes group):
- People under 18 years old who are able to give consent (or whose parent/guardian can consent on their behalf)
- People who have been diagnosed with prediabetes (as defined by the trial) (confirm with trial site)
- People who are able to drink a glucose drink within 10 minutes
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
Cohort 1:
- People with a known inherited blood condition affecting haemoglobin (a protein in red blood cells)
- People with diabetes caused by cystic fibrosis
- People who do not speak English
Cohort 2:
- People with a known inherited blood condition affecting haemoglobin
- People who have already been diagnosed with diabetes and are currently receiving treatment for it
- People who do not speak English
- People for whom no recent weight measurement is available (within the past 3 months) and where a new weight measurement cannot be taken
CGM Sub-study:
- People with a known inherited blood condition affecting haemoglobin
- People with diabetes caused by cystic fibrosis
- People who do not speak English
- People with an active skin condition that would prevent a glucose monitor device from being worn on the skin
Qualitative Sub-study:
- People who do not speak English
Cohort 3:
- People who have already been diagnosed with diabetes and are currently receiving treatment for it
- People who do not speak English
- People for whom no recent weight measurement is available (within the past 3 months) and where a new weight measurement cannot be taken
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +44 1865287578
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To determine the agreement of capillary blood glucose levels to venous blood glucose levels during a standard OGTT; To assess the feasibility of using the capillary OGTT device in the home environment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.